In silico-based vaccine design against Ebola virus glycoprotein
Ebola virus (EBOV) is one of the lethal viruses, causing more than 24 epidemic outbreaks to date. Despite having available molecular knowledge of this virus, no definite vaccine or other remedial agents have been developed yet for the management and avoidance of EBOV infections in humans. Disclosing...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
Dove Medical Press
2017
|
| Subjects: |